Patents by Inventor Douglas Lazarus

Douglas Lazarus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER
    Publication number: 20200093932
    Abstract: Provided are methods relating to the treatment of cancer with a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101 in combination with an inhibitor of the tryptophan metabolism pathway, e.g., an indoleamine-2,3-dioxygenase (IDO) inhibitor or a tryptophan-2, 3-dioxygenase (TDO) inhibitor.
    Type: Application
    Filed: December 1, 2017
    Publication date: March 26, 2020
    Inventors: Paul Friedman, Scott Eliasof, Adrian Senderowicz, Andres Tellez, Douglas Lazarus, Lata Jayaraman
  • Methods and compositions for treating inflammatory disorders
    Publication number: 20070219136
    Abstract: The present invention provides methods and compositions for treating inflammatory disorders, e.g., asthma, lung inflammation or cancer.
    Type: Application
    Filed: January 19, 2007
    Publication date: September 20, 2007
    Applicant: Praecis Pharmaceuticals, Inc.
    Inventors: Gerhard Hanning, Douglas Lazarus
  • Methods and compositions for treating inflammatory disorders
    Publication number: 20030083262
    Abstract: The present invention provides methods and compositions for treating inflammatory disorders, e.g., asthma, lung inflammation or cancer.
    Type: Application
    Filed: August 27, 2002
    Publication date: May 1, 2003
    Applicant: Praecis Pharmaceuticals Inc.
    Inventors: Gerhard Hannig, Douglas Lazarus